Impact BioMedical, INC. Earnings Per Share (Basic)
Impact BioMedical, INC. (IBO) reported Earnings Per Share (Basic) of -$0.01 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-07
- Impact BioMedical, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.01.
- Impact BioMedical, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.02.
- Impact BioMedical, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.12, a 132.43% decline year-over-year.
- Impact BioMedical, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$1.18.
- Impact BioMedical, INC. earnings per share, basic for fiscal 2025 was -$0.38.
- Impact BioMedical, INC. earnings per share, basic for fiscal 2024 was -$2.30.
- Impact BioMedical, INC. earnings per share, basic for fiscal 2023 was -$0.07.
- Impact BioMedical, INC. earnings per share, basic for fiscal 2022 was -$0.10.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.01 10-Q · filed 2026-08-07 | -$0.03 10-Q · filed 2026-08-07 | ||||
| 2026-03-31 | -$0.02 10-Q · filed 2026-05-12 | |||||
| 2025-12-31 | -$0.38 10-K · filed 2026-03-11 | |||||
| 2025-09-30 | -$0.12 10-Q · filed 2025-11-07 | -$1.41 10-Q · filed 2025-11-07 | ||||
| 2025-06-30 | -$1.18 10-Q · filed 2026-08-07 | -$1.29 10-Q · filed 2026-08-07 | ||||
| 2025-03-31 | -$0.11 10-Q · filed 2026-05-12 | |||||
| 2024-12-31 | -$2.30 10-K · filed 2026-03-11 | |||||
| 2024-09-30 | $0.37 10-Q · filed 2025-11-07 | $0.31 derived: net income ÷ weighted average shares · filed 2025-11-07 | $0.23 10-Q · filed 2025-11-07 | $0.08 derived: net income ÷ weighted average shares · filed 2025-11-07 | ||
| 2024-06-30 | -$0.09 10-Q · filed 2025-08-14 | -$0.18 10-Q · filed 2025-08-14 | -$0.19 derived: net income ÷ weighted average shares · filed 2025-08-14 | -$0.14 derived: net income ÷ weighted average shares · filed 2025-08-14 | ||
| 2024-03-31 | -$0.10 10-Q · filed 2025-05-14 | -$0.11 derived: net income ÷ weighted average shares · filed 2025-05-14 | -$0.09 derived: net income ÷ weighted average shares · filed 2025-05-14 | -$0.10 derived: net income ÷ weighted average shares · filed 2025-05-14 | ||
| 2023-12-31 | -$0.04 derived: net income ÷ weighted average shares · filed 2025-03-28 | -$0.05 derived: net income ÷ weighted average shares · filed 2025-03-28 | -$0.06 derived: net income ÷ weighted average shares · filed 2025-03-28 | -$0.07 10-K · filed 2025-03-28 | ||
| 2023-09-30 | -$0.02 10-Q · filed 2024-11-12 | -$0.03 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$0.04 10-Q · filed 2024-11-12 | -$0.09 derived: net income ÷ weighted average shares · filed 2024-11-12 | ||
| 2023-06-30 | -$0.02 10-Q · filed 2024-08-13 | $0.00 10-Q · filed 2023-10-05 | -$0.03 10-Q · filed 2024-08-13 | $0.00 10-Q · filed 2023-10-05 | -$0.07 derived: net income ÷ weighted average shares · filed 2024-08-13 | -$0.10 derived: net income ÷ weighted average shares · filed 2024-08-13 |
| 2023-03-31 | -$0.01 10-Q · filed 2024-05-10 | -$0.06 derived: net income ÷ weighted average shares · filed 2024-05-10 | -$0.09 derived: net income ÷ weighted average shares · filed 2024-05-10 | -$0.01 derived: net income ÷ weighted average shares · filed 2024-05-10 | ||
| 2022-12-31 | -$0.05 derived: net income ÷ weighted average shares · filed 2024-02-20 | -$0.08 derived: net income ÷ weighted average shares · filed 2024-02-20 | -$0.00 derived: net income ÷ weighted average shares · filed 2024-02-20 | -$0.10 10-K · filed 2024-02-20 | ||
| 2022-09-30 | -$0.03 10-Q · filed 2023-11-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$0.06 10-Q · filed 2023-11-13 | |||
| 2022-06-30 | $0.00 10-Q · filed 2023-10-05 | $0.00 10-Q · filed 2023-10-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |